Non-HFE-related hereditary iron overload;Surcharges en fer héréditaires non liées au gène HFE

Presse Medicale

Volumn 36, Issue 9 II, 2007, Pages 1279-1291

  Aguilar Martinez, Patricia ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE MESYLATE; HEPCIDIN; HFE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN; TRANSFERRIN RECEPTOR 2; ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; METAL TRANSPORTING PROTEIN 1; SOLUTE CARRIER FAMILY 11 (PROTON COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2; TFR2 PROTEIN, HUMAN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANEMIA; CLINICAL FEATURE; FRIEDREICH ATAXIA; GENE MUTATION; GENETIC DISORDER; HEMOCHROMATOSIS; IRON INTAKE; IRON OVERLOAD; MUTATOR GENE; NEUROLOGIC DISEASE; NEUROPATHY; NONHUMAN; PHLEBOTOMY; SHORT SURVEY; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MEMBRANE PROTEINS; RECEPTORS, TRANSFERRIN;

EID: 34548286934     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.01.042     Document Type: Short Survey

References (56)

1. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
2. Aguilar Martinez P., Biron C., Blanc F., Masmejean C., Jeanjean P., Michel H., et al. Compound heterozygotes for hemochromatosis gene mutations : may they help to understand the pathophysiology of the disease?. Blood Cells Mol Dis 23 (1997) 269-276
3. Walsh A., Dixon J.L., Ramm G.A., Hewett D.G., Lincoln D.J., Anderson G.J., et al. The Clinical Relevance of Compound Heterozygosity for the C282Y and H63D Substitutions in Hemochromatosis. Clin Gastroenterol Hepatol 4 (2006) 1403-1410
4. Tomatsu S., Orii K.O., Fleming R.E., Holden C.C., Waheed A., Britton R.S., et al. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc Natl Acad Sci USA 100 (2003) 15788-15793
5. Aguilar-Martinez P., Bismuth M., Picot M.C., Thelcide C., Pageaux G.P., Blanc F., et al. Variable phenotypic presentation of iron overload in H63D homozygotes : are genetic modifiers the cause?. Gut 48 (2001) 836-842
6. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., and Gelbart T. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359 (2002) 211-218
7. Merryweather-Clarke A.T., Cadet E., Bomford A., Capron D., Viprakasit V., Miller A., et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 12 (2003) 2241-2247
8. Le Gac G., Scotet V., Ka C., Gourlaouen I., Bryckaert L., Jacolot S., et al. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 13 (2004) 1913-1918
9. Njajou O.T., Vaessen N., Joosse M., Berghuis B., van Dongen J.W., Breuning M.H., et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28 (2001) 213-214
10. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108 (2001) 619-623
11. Simon M., Bourel M., Fauchet R., and Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 17 (1976) 332-334
12. Girelli D., Corrocher R., Bisceglia L., Olivieri O., De Franceschi L., Zelante L., et al. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome : a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood 86 (1995) 4050-4053
13. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25 (2000) 14-15
14. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33 (2003) 21-22
15. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36 (2004) 77-82
16. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106 (2005) 1092-1097
17. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38 (2006) 531-539
18. Mims M.P., Guan Y., Pospisilova D., Priwitzerova M., Indrak K., Ponka P., et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105 (2005) 1337-1342
19. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
20. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
21. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98 (2001) 8780-8785
22. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
23. Nemeth E., Roetto A., Garozzo G., Ganz T., and Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105 (2005) 1803-1806
24. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2 (2005) 399-409
25. Pietrangelo A. Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut 55 (2006) 564-568
26. Aguilar Martinez P., and Schved J.F. Vers une classification raisonnée des surcharges en fer et des hyperferritinémies d'origine génétique. Hématologie. 10 (2004) 275-285
27. Adams P., Brissot P., and Powell L.W. EASL International Consensus Conference on Haemochromatosis. J Hepatol 33 (2000) 485-504
28. Cazzola M., Ascari E., Barosi G., Claudiani G., Dacco M., Kaltwasser J.P., et al. Juvenile idiopathic haemochromatosis : a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet 65 (1983) 149-154
29. Piperno A., Roetto A., Mariani R., Pelucchi S., Corengia C., Daraio F., et al. Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. Haematologica 89 (2004) 359-360
30. Riva A., Mariani R., Bovo G., Pelucchi S., Arosio C., Salvioni A., et al. Type 3 hemochromatosis and beta-thalassemia trait. Eur J Haematol 72 (2004) 370-374
31. Aguilar-Martinez P., Esculie-Coste C., Bismuth M., Giansily-Blaizot M., Larrey D., and Schved J.F. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Blood Cells Mol Dis 27 (2001) 290-293
32. Lee P.L., Halloran C., West C., and Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis 27 (2001) 285-289
33. Pietrangelo A., Caleffi A., Henrion J., Ferrara F., Corradini E., Kulaksiz H., et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128 (2005) 470-479
34. De Gobbi M., Roetto A., Piperno A., Mariani R., Alberti F., Papanikolaou G., et al. Natural history of juvenile haemochromatosis. Br J Haematol 117 (2002) 973-979
35. Roetto A., Totaro A., Cazzola M., Cicilano M., Bosio S., D'Ascola G., et al. Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 64 (1999) 1388-1393
36. Lee P.L., Beutler E., Rao S.V., and Barton J.C. Genetic abnormalities and juvenile hemochromatosis : mutations of the HJV gene encoding hemojuvelin. Blood 103 (2004) 4669-4671
37. Lanzara C., Roetto A., Daraio F., Rivard S., Ficarella R., Simard H., et al. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103 (2004) 4317-4321
38. Fleming R.E., and Sly W.S. Hepcidin : a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 98 (2001) 8160-8162
39. Nicolas G., Viatte L., Lou D.Q., Bennoun M., Beaumont C., Kahn A., et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34 (2003) 97-101
40. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 32 (2004) 131-138
41. Cazzola M. Genetic disorders of iron overload and the novel "ferroportin disease". Haematologica 88 (2003) 721-724
42. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105 (2005) 4096-4102
43. Beaumont C., Leneuve P., Devaux I., Scoazec J.Y., Berthier M., Loiseau M.N., et al. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet 11 (1995) 444-446
44. Pospisilova D., Mims M.P., Nemeth E., Ganz T., and Prchal J.T. DMT1 mutation : response of anemia to darbepoetin administration and implications for iron homeostasis. Blood 108 (2006) 404-405
45. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Morita H., et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9 (1995) 267-272
46. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28 (2001) 350-354
47. Gordeuk V.R., Caleffi A., Corradini E., Ferrara F., Jones R.A., Castro O., et al. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol Dis 31 (2003) 299-304
48. Beutler E., Barton J.C., Felitti V.J., Gelbart T., West C., Lee P.L., et al. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 31 (2003) 305-309
49. Whitington P.F., Kelly S., and Ekong U.D. Neonatal hemochromatosis : fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant 9 (2005) 640-645
50. Whitington P.F., and Hibbard J.U. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364 (2004) 1690-1698
51. Hetet G., Devaux I., Soufir N., Grandchamp B., and Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 102 (2003) 1904-1910
52. Matthes T., Aguilar-Martinez P., Pizzi-Bosman L., Darbellay R., Rubbia-Brandt L., Giostra E., et al. Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene. Blood 104 (2004) 2181-2183
53. Borgna-Pignatti C., Cappellini M.D., De Stefano P., Del Vecchio G.C., Forni G.L., Gamberini M.R., et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 107 (2006) 3733-3737
54. Fabio G., Minonzio F., Delbini P., Bianchi A., and Cappellini M.D. Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by severe type of juvenile hemochromatosis (JH) (2006), Blood
55. Aguilar-Martinez P., Lok C.Y., Cunat S., Cadet E., Robson K., and Rochette J. Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V/R176C mutations in a 5-year old girl. Haematologica 92 (2007) 421-422
56. Gasparini P., and Camaschella C. Hereditary hemochromatosis : is the gene race over?. Eur J Hum Genet 12 (2004) 341-342